Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 63 of 1,261
  1. US 12221607

    Multi-targeted single entity conjugates

    Alnylam Pharmaceuticals, Inc. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  2. US 12221463

    Method of promoting wound healing by inhibiting CCR3

    The Board of Regents of the University of Oklahoma · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  3. US 12220421

    Inhibitors of C. difficile spore germination

    THE BOARDS OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  4. US 12220453

    Compositions and treatments for Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  5. US 12220420

    Combination therapy for cancer treatment

    Galera Labs, LLC · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  6. US 12222355

    Therapeutic antibodies against ROR-1 protein and methods for use of same

    The Regents of the University of California · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  7. US 12221491

    PSMD9 inhibitors for the treatment of hepatic lipid dysregulation

    The Regents of the University of California · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  8. US 12223643

    Machine-learning system for diagnosing disorders and diseases and determining drug responsiveness

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  9. US 12221612

    Plants having increased oil quality

    Regents of the University of Minnesota · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  10. US 12221627

    Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  11. US 12221622

    Modified pluripotent cells

    The Regents of the University of California · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  12. US 12221452

    Synthesis of cantharidin

    Verrica Pharmaceuticals Inc. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  13. US 12221441

    Plasma kallikrein inhibitors and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  14. US 12221483

    Fusion protein and nucleic acid encoding sequence thereof, and uses of the same

    China Medical University Hospital · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  15. US 12221460

    Antibody drug conjugates

    Takeda Pharmaceutical Company Limited · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  16. US 12221629

    Methods for producing fibroadipogenic progenitor cells

    Regents of the University of Minnesota · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  17. US 12221462

    Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

    Allogene Therapeutics, Inc. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  18. US 12220455

    Coronavirus vaccine compositions and methods

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  19. US 12221422

    Compounds and their use for the treatment of alpha1-antitrypsin deficiency

    CENTESSA PHARMACEUTICALS (UK) LIMITED · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  20. US 12220415

    WEE1 kinase inhibitors and methods of treating cancer using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  21. US 12220446

    Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF

    THE FIRST AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  22. US 12220424

    Compositions comprising nicotinamide riboside and a urolithin

    Amazentis SA · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  23. WO 2025027551

    VACCIN ANTI-IBV AVEC PROTÉINE DE SPICULE DE DMV/1639 HÉTÉROLOGUE

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Feb 6, 2025 · Expires Feb 1, 2045

    granted
  24. WO 2025030001

    PROCÉDÉS ET COMPOSITIONS POUR LE MAINTIEN DE LA MOBILITÉ ET/OU DE LA MASSE DES MUSCLES SQUELETTIQUES, ET/OU POUR LA RÉCUPÉRATION DE LA FORCE DES MUSCLES SQUELETTIQUES

    ABBOTT LAB [US] · Granted Feb 6, 2025 · Expires Feb 1, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.